+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Management"

From
From
From
From
From
From
Cancer Biopsy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cancer Biopsy Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Lung Cancer. Edition No. 4 - Product Thumbnail Image

Lung Cancer. Edition No. 4

  • Book
  • May 2014
  • 616 Pages
Tumor Microenvironment. Edition No. 1 - Product Thumbnail Image

Tumor Microenvironment. Edition No. 1

  • Book
  • October 2010
  • 454 Pages
Loading Indicator

The Cancer Management market within the context of Oncology is a rapidly growing sector of the healthcare industry. It encompasses a wide range of services, products, and technologies that are used to diagnose, treat, and manage cancer. This includes treatments such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy, as well as diagnostic tests, imaging, and other supportive care services. The market also includes a variety of products and services related to cancer prevention, such as screening tests, lifestyle modifications, and genetic testing. The Cancer Management market is driven by advances in technology, increasing prevalence of cancer, and the growing demand for personalized treatments. Additionally, the increasing availability of healthcare services and the rising awareness of cancer among the general population are also contributing to the growth of the market. Some of the major companies in the Cancer Management market include Roche, Novartis, Merck, Pfizer, Bristol-Myers Squibb, AstraZeneca, and Johnson & Johnson. Show Less Read more